While treatment with WT IL-2 or PD1-IL2v increased the frequencies of better effectors in chronic LCMV infection or in Panc02-Fluc pancreatic adenocarcinoma, this effect was not observed upon treatment with IL-2v, which was not targeted to T cells [8,11] (Figure 2B). Here, IL2 is linked to pancreatic adenocarcinoma.